Johnson & Johnson halts sale of device used in fibroid surgery

American pharmaceutical giant Johnson & Johnson has suspended sales of the devices used in fibroid surgery amid concerns about their potential to spread a rare but deadly cancer, reported The Wall Street Journal.

EU backs J&J`s TB drug, postpones decision on Teva MS pill

European regulators on Friday recommended approval of an innovative tuberculosis drug from Johnson & Johnson but postponed a keenly awaited decision on a new multiple sclerosis pill from Teva Pharmaceutical Industries.

J&J to pay $2.2 bn to end US drug probes

Global healthcare giant Johnson & Johnson and its subsidiaries have agreed to pay more than $2.2 billion to resolve criminal and civil investigations for misbranding anti-psychotic drugs and paying kickbacks to pharmacists, the US Department of Justice said.

FDA approves new tuberculosis drug

The drug named Sirturo - known chemically as bedaquilineas – is an alternative treatment for adults suffering from TB.

Johnson & Johnson in trouble

Johnson & Johnson is facing a multi-million-pound legal claim for faulty hip replacement operations.

Johnson & Johnson in trouble

Johnson & Johnson is facing a multi-million-pound legal claim for faulty hip replacement operations.

Johnson & Johnson to cut more than 7,000 jobs worldwide

Johnson & Johnson, a leading US health care products company, said on Tuesday that it will slash between six and seven percent of its global workforce, more than 7,000 jobs, to cut costs.